Week in Review
Secretary Robert F. Kennedy Jr. is pushing the FDA to expand patient access to peptides despite concerns over unapproved uses.
Mixed
tl;dr
This regulatory roundup covers a major Ticketmaster antitrust verdict, the House passage of the aviation-focused ALERT Act, and potential FDA shifts in peptide regulation driven by HHS Secretary Robert F. Kennedy Jr.
How does this look for
RFRobert F. Kennedy Jr.R-
tap to vote
45%55%
14 votes · rated by people, not pundits
Discussion
What's your take?
Loading comments...